Original Research
Published on 14 Aug 2020
Hypoxia-Induced Adipose Lipolysis Requires Fibroblast Growth Factor 21
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01279
- 3,914 views
- 15 citations
Type at least 3 characters
926 articles
Articles
Review
Published on 13 Aug 2020
Natural Products Impacting DNA Methyltransferases and Histone Deacetylases
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00992
- 11,743 views
- 37 citations
Review
Published on 13 Aug 2020
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01230
- 13,809 views
- 26 citations
Review
Published on 12 Aug 2020
Lysine Acetyltransferase Inhibitors From Natural Sources
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01243
- 9,633 views
- 25 citations
Original Research
Published on 12 Aug 2020
Attenuation of Radiation-Induced Lung Injury by Hyaluronic Acid Nanoparticles
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01199
- 4,622 views
- 18 citations
Opinion
Published on 07 Aug 2020
Direct Oral Provocation Test Is Safe and Effective in Diagnosing Beta-Lactam Allergy in Low-Risk Children With Mild Cutaneous Reactions
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01223
- 4,127 views
- 9 citations
Review
Published on 07 Aug 2020
SIRT1 Activation by Natural Phytochemicals: An Overview
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01225
- 54,524 views
- 183 citations
Review
Published on 07 Aug 2020
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01161
- 18,217 views
- 83 citations
Review
Published on 06 Aug 2020
COVID-19 Therapeutic Options Under Investigation
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01196
- 16,113 views
- 74 citations
Hypothesis and Theory
Published on 05 Aug 2020
DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19—A Therapeutic Approach of Choice in Type 2 Diabetic Patients?
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01185
- 5,240 views
- 22 citations
Original Research
Published on 05 Aug 2020
Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.00921
- 4,133 views
- 10 citations
Original Research
Published on 29 Jul 2020
Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01103
- 4,123 views
- 2 citations
Opinion
Published on 29 Jul 2020
Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01156
- 3,033 views
- 17 citations
Review
Published on 24 Jul 2020
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01132
- 93,702 views
- 192 citations
Original Research
Published on 15 Jul 2020
Improving the Therapeutic Effect of Ultrasound Combined With Microbubbles on Muscular Tumor Xenografts With Appropriate Acoustic Pressure
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01057
- 1,988 views
- 5 citations
Review
Published on 08 Jul 2020
Advance in Drug Delivery for Ageing Skeletal Muscle
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01016
- 10,106 views
- 14 citations